Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bristol-myers squibb company crawled time : 17:00 save search
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -2.93%
NVO | News | $126.16 -1.93% -2.24% 3M
|
Health Technology
|
| O: -0.31%
H: 0.39%
C: -0.44%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.18%
H: 0.5%
C: -0.46%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: 0.52%
H: 0.58%
C: 0.05%
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 0.34%
H: 1.02%
C: 0.59%
BIIB | $201.99 4.56% 4.32% 2.7M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.04%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.06%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.24%
H: 2.03%
C: 1.49%
patent report global market
Global HIV Drugs Market Research Report 2023-2031: Long-Acting Injectable HIV Therapies Redefining the Treatment Landscape
Published: 2023-10-02 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -0.5%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.05%
H: 0.09%
C: -0.28%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
report treatment research global hiv market
Rare Diseases Global Market Report 2023: Revenue Set to Surpass $205 Billion in 2023
Published: 2023-07-03 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -1.21%
H: 0.03%
C: -0.92%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.71%
H: 0.03%
C: -0.6%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.02%
H: 1.51%
C: 0.77%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.54%
H: 1.07%
C: 0.75%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.24%
H: 0.0%
C: 0.0%
BIIB | $201.99 4.56% 4.32% 2.7M
|
Health Technology
|
| O: -0.7%
H: 0.98%
C: 0.91%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: -0.36%
H: 1.97%
C: 1.72%
rare report global set market
Bristol Myers Squibb to Present Late-Breaking Data for Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma at 2023 International Conference on Malignant Lymphoma
Published: 2023-05-30 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.71%
H: 1.14%
C: 0.54%
conference breyanzi international cell
Global Mouth Ulcer Treatment Market to 2027: Increasing Oral Problems Worldwide Bolsters Growth
Published: 2023-04-05 (Crawled : 17:00) - prnewswire.com
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.8%
H: 1.07%
C: 0.52%
MMM | $92.02 -1.05% 0.17% 2.7M
|
Producer Manufacturing
|
| O: 0.11%
H: 0.4%
C: -0.07%
treatment global growth market
Cervical Cancer Drugs Global Market Report 2023
Published: 2023-02-16 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -1.48%
H: 0.55%
C: 0.08%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -1.2%
H: 0.58%
C: -1.49%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.94%
H: 0.59%
C: 0.07%
global report cancer market
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -1.52%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 1.26%
H: 1.19%
C: 1.19%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.31%
H: 1.15%
C: 0.68%
NVO | News | $126.16 -1.93% -2.24% 3M
|
Health Technology
|
| O: 0.13%
H: 0.65%
C: 0.51%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.1%
H: 0.31%
C: 0.17%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -0.43%
H: 1.33%
C: 0.3%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.36%
C: 1.02%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.1%
H: 0.97%
C: -0.37%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.29%
H: 2.1%
C: 1.94%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.17%
H: 1.07%
C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 0.51%
H: 0.49%
C: -0.65%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: -0.9%
H: 0.58%
C: 0.01%
global report growth market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA 4 | $11.71 -1.27% -1.45% 2.9M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO | $10.16 -2.03% -2.67% 250K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $67.08 0.08% 0.06% 6.2M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.7147 -0.54% -1.2% 640K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Money on the Move: Arsenal, ILiAD and a Hefty Gift to UCSD
Published: 2022-09-07 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.03%
H: 1.18%
C: 0.13%
Gritstone Announces Updated Overall Survival Results in Advanced Colorectal Cancer Patients from Phase 1/2 Study of GRANITE and Trial in Progress Poster at ASCO
Published: 2022-05-31 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -1.39%
H: 1.2%
C: 0.49%
GRTS | $0.8129 10.06% 9.92% 1.8M
|
Health Technology
|
| O: 7.03%
H: 18.69%
C: 2.02%
trial asco results cancer phase 1
The Worldwide Urinary Tract Infection Treatment Industry is Expected to Reach $11.39 Billion by 2027
Published: 2022-05-13 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 1.46%
H: 0.46%
C: 0.46%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.86%
H: 0.31%
C: -0.34%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.99%
H: 1.05%
C: 1.0%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
treatment expected infection infections
Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
kidney disease dialysis
Biohaven and Pfizer Complete Collaboration Transaction for Commercialization of Rimegepant and Zavegepant Outside United States
Published: 2022-01-05 (Crawled : 17:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $38.72 -2.25% 0.83% 970K
|
Health Technology
|
| O: 0.43%
H: 0.9%
C: -4.35%
commercialization collaboration
Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight
Published: 2021-12-14 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: -1.42%
H: 0.02%
C: 0.02%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: -1.44%
H: 5.82%
C: 1.91%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: -1.37%
H: 0.68%
C: 0.37%
NVO | News | $126.16 -1.93% -2.24% 3M
|
Health Technology
|
| O: -1.8%
H: 0.08%
C: -0.43%
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
|
| O: -0.2%
H: 0.66%
C: -0.52%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.92%
C: 0.66%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 2.71%
H: 2.77%
C: 1.21%
BDX | $233.83 -0.23% 0.0% 780K
|
Health Technology
|
| O: -0.3%
H: 0.1%
C: -1.63%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
PODD | $167.25 -0.01% -0.03% 660K
|
Health Technology
|
| O: -0.82%
H: 0.38%
C: -2.71%
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: -5.76%
H: 7.53%
C: 0.47%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: -0.31%
H: 0.7%
C: -0.63%
drug liver growing drug delivery
Late-Breaking Phase 2 Data for Investigational Oral Factor XIa Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across a Wide Range of Doses
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 1.63%
H: 0.43%
C: -0.3%
phase 2
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Published: 2021-11-01 (Crawled : 17:00) - prnewswire.com
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.17%
H: 1.58%
C: 0.65%
New Cancer Therapies Continue to Develop and Give Hope in Rapidly Improving Oncology Space
Published: 2021-09-20 (Crawled : 17:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -1.74%
H: 2.9%
C: 1.87%
MRK | $127.0 0.1% 0.63% 5.7M
|
Health Technology
|
| O: -0.14%
H: 2.04%
C: 1.08%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.18%
H: 1.22%
C: -0.23%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.52%
H: 9.63%
C: 3.06%
space cancer spac therapy
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma
Published: 2021-08-20 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
food treatment risk drug nivolumab urothelial carcinoma
Virpax® Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board
Published: 2021-07-30 (Crawled : 17:00) - biospace.com/
VRPX | $3.19 0.95% 0.94% 4.7K
|
|
| O: 2.0%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors
Published: 2021-06-14 (Crawled : 17:00) - biospace.com/
BMY | $48.86 -0.27% 1.0% 14M
|
Health Technology
|
| O: -0.03%
H: 0.19%
C: -0.04%
NKTR | News | $1.38 -2.82% -2.16% 960K
|
Health Technology
|
| O: 0.62%
H: 2.31%
C: -0.23%
EXEL | $23.71 1.8% 1.73% 1.6M
|
Health Technology
|
| O: 0.48%
H: 1.08%
C: -1.43%
solid tumors collaboration trial therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.75 36.97% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.